54 results
8-K
XENE
Xenon Pharmaceuticals Inc
2 Jun 22
Departure of Directors or Certain Officers
4:03pm
, please refer to the disclosure found under “Executive Compensation—Employee Benefit and Stock Plans—Amended and Restated 2014 Equity Incentive Plan
8-K
pdidxq7g
10 Mar 22
Results of Operations and Financial Condition
4:09pm
424B5
jqcc13 p4cy7k9kv1
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
isqaqaf
6 Oct 21
Prospectus supplement for primary offering
5:05pm
424B5
ipsha46t08e
4 Oct 21
Prospectus supplement for primary offering
5:27pm
8-K
mwqiyuuzbw7rgq0
12 Mar 21
Departure of Directors or Certain Officers
5:03pm
8-K
7d9m81sfmrs uc9o
13 Mar 20
Departure of Directors or Certain Officers
4:05pm
424B5
d5tkgz0
23 Jan 20
Prospectus supplement for primary offering
4:44pm
424B5
8rb8ov izhip2e
22 Jan 20
Prospectus supplement for primary offering
4:11pm